Back to all people

Rafia Bhore

Regeneron Pharmaceuticals

3 appearances in the program

Sessions & presentations

PS44: Co-Development of Single or Multi-Target Therapies in Combination: Statistical, Clinical, and Regulatory Issues in Trial Designs

Parallel · Fri, Sep 26 , 1:30 PM

Organizer

PS44: Co-Development of Single or Multi-Target Therapies in Combination: Statistical, Clinical, and Regulatory Issues in Trial Designs

Presentation: Statistical Perspectives on Design and Analysis of Early through Late-Phase Clinical Trials of Combination Drugs

Parallel · Fri, Sep 26 , 1:30 PM

Presenting Author

PS44: Co-Development of Single or Multi-Target Therapies in Combination: Statistical, Clinical, and Regulatory Issues in Trial Designs

Presentation: Panelist Discussion

Parallel · Fri, Sep 26 , 1:30 PM

Panelist

↑